SATO VICKI L
SEC insider (Form 3/4/5 filer). CIK 0001197020. Director at Allogene Therapeutics, Inc. (ALLO) and 2 other issuers. 25 reported Form 4/5 transactions since Sep 2024; latest on Jun 18, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies SATO VICKI L has filed insider reports for
- Allogene Therapeutics, Inc. (ALLO): Director
- Vir Biotechnology, Inc. (VIR): Director
- Denali Therapeutics Inc. (DNLI): Director
SATO VICKI L
CIK: 0001197020
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (25 total)
- Jun 18, 2026ALLO
Allogene Therapeutics, Inc.
AwardDirectRestricted Stock Unit
95.4K shares- - May 1, 2026VIR
Vir Biotechnology, Inc.
SaleDirect22K shares at avg. $10.05$221K - Apr 1, 2026VIR
Vir Biotechnology, Inc.
SaleDirect22K shares at avg. $9.07$200K - Mar 2, 2026VIR
Vir Biotechnology, Inc.
SaleDirect21.8K shares at avg. $9.50$207K - Mar 2, 2026VIR
Vir Biotechnology, Inc.
SaleDirect200 shares at avg. $9.98$2K - Feb 24, 2026VIR
Vir Biotechnology, Inc.
SaleDirect200 shares at avg. $10.26$2K - Feb 24, 2026VIR
Vir Biotechnology, Inc.
SaleDirect42.2K shares at avg. $9.75$411K - Feb 24, 2026VIR
Vir Biotechnology, Inc.
ExerciseDirect42.4K shares at avg. $1.49$63K - Feb 2, 2026VIR
Vir Biotechnology, Inc.
SaleDirect22K shares at avg. $7.71$170K - Jan 2, 2026VIR
Vir Biotechnology, Inc.
SaleDirect22K shares at avg. $5.93$130K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 18, 2026 |  ALLO Allogene Therapeutics, Inc. | Award Restricted Stock Unit | 95,400 | - | - | Direct |
| May 1, 2026 |  VIR Vir Biotechnology, Inc. | Sale | 22,000 | $10.05 | $221,025 | Direct |
| Apr 1, 2026 | VIR Vir Biotechnology, Inc. | Sale | 22,000 | $9.07 | $199,617 | Direct |
| Mar 2, 2026 | VIR Vir Biotechnology, Inc. | Sale | 21,800 | $9.50 | $207,185 | Direct |
| Mar 2, 2026 | VIR Vir Biotechnology, Inc. | Sale | 200 | $9.98 | $1,996 | Direct |
| Feb 24, 2026 | VIR Vir Biotechnology, Inc. | Sale | 200 | $10.26 | $2,052 | Direct |
| Feb 24, 2026 | VIR Vir Biotechnology, Inc. | Sale | 42,177 | $9.75 | $411,314 | Direct |
| Feb 24, 2026 | VIR Vir Biotechnology, Inc. | Exercise | 42,377 | $1.49 | $62,930 | Direct |
| Feb 2, 2026 | VIR Vir Biotechnology, Inc. | Sale | 22,000 | $7.71 | $169,671 | Direct |
| Jan 2, 2026 | VIR Vir Biotechnology, Inc. | Sale | 22,000 | $5.93 | $130,383 | Direct |
1-10 of 25 transactions